Home/Aspargo Laboratories/Sam Backenroth

SB

Sam Backenroth

Chief Financial Officer

Aspargo Laboratories

Therapeutic Areas

Oncology Immunology Urology

Aspargo Laboratories Pipeline

Drug	Indication	Phase
ASP-001	Erectile Dysfunction	Approved
Undisclosed Pipeline	Various (Rx & OTC)	Pre-clinical/Development

Leadership Team at Aspargo Laboratories

Michael Demurjian

Chief Executive Officer & Chairman

Steven Kaplan, MD

Chief Medical Officer

Mario Guralnik, Ph.D.

Chief Regulatory Officer

View full Aspargo Laboratories profile